{"schema_version":"secwatch.filing_event.v1","accession":"0001326110-23-000028","form_type":"8-K","ticker":"IBRX","cik":"0001326110","company_name":"ImmunityBio, Inc.","filed_at":"2023-03-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.418235+00:00","generated_at":"2026-06-17T07:39:41.243130+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"ImmunityBio issues $30M convertible promissory note to Nant Capital, LLC","bullets":["$30M principal, Term SOFR + 8% interest, due Dec 31, 2023.","Investor is Nant Capital, LLC, affiliated with Executive Chairman Dr. Patrick Soon-Shiong.","Net proceeds $29.85M after 0.5% origination fee; funds for pre-commercialization, R&D, and corporate purposes.","Convertible at holder's option after next insider trading window opens at greater of Nasdaq closing or bid price."],"urls":{"canonical":"https://secwatch.observer/filing/0001326110-23-000028","json":"https://secwatch.observer/filing/0001326110-23-000028.json","markdown":"https://secwatch.observer/filing/0001326110-23-000028.md","text":"https://secwatch.observer/filing/0001326110-23-000028.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326110/000132611023000028/0001326110-23-000028-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326110/000132611023000028/ibrx-20230331.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T07:39:41.243130+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"05e2eb38950f58379c3a844cf0a2fcbcf4122047","claim":"ImmunityBio, Inc. entered into $30.0 million convertible promissory note with Nant Capital, LLC valued at $30.0 million (effective 2023-03-31).","evidence_excerpt":"On March 31, 2023, ImmunityBio, Inc. (the “Company”) executed a $30.0 million convertible promissory note with Nant Capital, LLC","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611023000028/0001326110-23-000028-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"notes offering"},{"label":"Counterparty","value":"Nant Capital, LLC"},{"label":"Value","value":"$30.0 million"},{"label":"Effective","value":"2023-03-31"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}